Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 5
2021 9
2022 5
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging.
Corrias G, Lai E, Ziranu P, Mariani S, Donisi C, Liscia N, Saba G, Pretta A, Persano M, Fanni D, Spanu D, Balconi F, Loi F, Deidda S, Restivo A, Pusceddu V, Puzzoni M, Solinas C, Massa E, Madeddu C, Gerosa C, Zorcolo L, Faa G, Saba L, Scartozzi M. Corrias G, et al. Among authors: donisi c. Cancers (Basel). 2024 Mar 30;16(7):1364. doi: 10.3390/cancers16071364. Cancers (Basel). 2024. PMID: 38611042 Free PMC article. Review.
Immunotherapy and Cancer: The Multi-Omics Perspective.
Donisi C, Pretta A, Pusceddu V, Ziranu P, Lai E, Puzzoni M, Mariani S, Massa E, Madeddu C, Scartozzi M. Donisi C, et al. Int J Mol Sci. 2024 Mar 21;25(6):3563. doi: 10.3390/ijms25063563. Int J Mol Sci. 2024. PMID: 38542536 Free PMC article. Review.
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapy.
Pretta A, Ziranu P, Giampieri R, Pinna G, Randon G, Donisi C, Ravarino A, Loi F, Deias G, Palmas E, Pretta G, Morano F, Semonella F, Mariani S, Deidda MA, Pusceddu V, Puzzoni M, Lai E, Solinas C, Restivo A, Zorcolo L, Barbara R, Berardi R, Faa G, Pietrantonio F, Scartozzi M. Pretta A, et al. Among authors: donisi c. Br J Cancer. 2023 Nov;129(10):1619-1624. doi: 10.1038/s41416-023-02444-2. Epub 2023 Sep 25. Br J Cancer. 2023. PMID: 37749283
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score.
Ziranu P, Ferrari PA, Guerrera F, Bertoglio P, Tamburrini A, Pretta A, Lyberis P, Grimaldi G, Lai E, Santoru M, Bardanzellu F, Riva L, Balconi F, Della Beffa E, Dubois M, Pinna-Susnik M, Donisi C, Capozzi E, Pusceddu V, Murenu A, Puzzoni M, Mathieu F, Sarais S, Alzetani A, Luzzi L, Solli P, Paladini P, Ruffini E, Cherchi R, Scartozzi M. Ziranu P, et al. Among authors: donisi c. Lung Cancer. 2023 Oct;184:107342. doi: 10.1016/j.lungcan.2023.107342. Epub 2023 Aug 9. Lung Cancer. 2023. PMID: 37573705
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors.
Ziranu P, Pretta A, Pozzari M, Maccioni A, Badiali M, Fanni D, Lai E, Donisi C, Persano M, Gerosa C, Puzzoni M, Bardanzellu F, Ambu R, Pusceddu V, Dubois M, Cerrone G, Migliari M, Murgia S, Spanu D, Pretta G, Aimola V, Balconi F, Murru S, Faa G, Scartozzi M. Ziranu P, et al. Among authors: donisi c. Sci Rep. 2023 Mar 16;13(1):4397. doi: 10.1038/s41598-023-31538-3. Sci Rep. 2023. PMID: 36928082 Free PMC article.
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer.
Madeddu C, Busquets S, Donisi C, Lai E, Pretta A, López-Soriano FJ, Argilés JM, Scartozzi M, Macciò A. Madeddu C, et al. Among authors: donisi c. Cancers (Basel). 2023 Feb 8;15(4):1076. doi: 10.3390/cancers15041076. Cancers (Basel). 2023. PMID: 36831431 Free PMC article.
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment.
Pretta A, Ziranu P, Giampieri R, Donisi C, Cimbro E, Spanu D, Lai E, Pecci F, Balconi F, Lupi A, Pozzari M, Persano M, Murgia S, Pusceddu V, Puzzoni M, Berardi R, Scartozzi M. Pretta A, et al. Among authors: donisi c. Dig Liver Dis. 2023 May;55(5):655-660. doi: 10.1016/j.dld.2022.11.012. Epub 2022 Dec 10. Dig Liver Dis. 2023. PMID: 36513569
25 results